Skip to main content

Can Untreated Sleep Apnea Be Fatal? What the Research Actually Says

Date Published

Can Untreated Sleep Apnea Be Fatal What the Research Actually Says

Untreated severe sleep apnea raises all-cause mortality 2 to 3 times. The lethal pathways are cardiovascular, not the breathing pauses themselves. Here's what the data shows and what changes with treatment.

Quick answer: Yes, severe untreated obstructive sleep apnea is associated with a roughly 2 to 3 times higher risk of all-cause mortality, mostly through cardiovascular events like heart attack, stroke, and arrhythmia. Sleep apnea itself rarely kills someone during a single breathing pause. The lethal pathway is years of nightly oxygen drops driving heart and brain disease. CPAP therapy reverses most of that excess risk.

This is one of the most-asked questions in our intake calls, and the honest answer surprises people. The breathing pauses themselves aren't what cause sudden death, your body wakes you up. What causes harm is the cumulative effect: every night, dozens to hundreds of partial wake-ups, each accompanied by a drop in blood oxygen and a surge in adrenaline. Years of that pattern strain the cardiovascular system. The endpoint is heart disease, stroke, and arrhythmia.

The hopeful part: this risk is treatable. Studies show that CPAP-adherent patients with severe OSA reach the cardiovascular mortality of patients without OSA within a few years of consistent therapy. Treatment works.

How does untreated sleep apnea cause death?

Researchers have mapped four primary pathways from untreated OSA to fatal events:

  • Cardiovascular disease. Each apnea episode triggers a sympathetic nervous system surge — heart rate spikes, blood pressure climbs. Repeated nightly for years, this drives sustained hypertension and accelerates atherosclerosis.
  • Atrial fibrillation. Untreated OSA roughly quadruples the risk of new-onset AFib. AFib in turn raises stroke risk fivefold.
  • Stroke. Independent of AFib, OSA itself raises ischemic stroke risk by about 60% in moderate-to-severe cases.
  • Drowsy driving. Crash risk for untreated OSA drivers is roughly twice that of non-apneic drivers. The FMCSA flags this for commercial drivers specifically.

How big is the mortality risk?

The most-cited dataset is the Wisconsin Sleep Cohort, which followed 1,522 adults for 18 years. Among participants with severe OSA who never received treatment, all-cause mortality ran roughly 3 times higher than untreated participants without OSA. Cardiovascular mortality specifically ran about 5 times higher. Treated participants had outcomes statistically indistinguishable from the OSA-free group.

Replication studies in different populations have produced consistent findings. The size of the effect varies, some show 2 times higher mortality, some 3 times, but the direction and the cardiovascular dominance of the pathway are reproducible.

Can sleep apnea cause sudden death during sleep?

It can, but it is rare. The body's response to apnea is a partial arousal that restores breathing. The arousals themselves are protective. Sudden cardiac death during a single apnea event happens almost exclusively in patients with severe pre-existing heart disease.

What does happen during sleep, and is more relevant for most patients: heart rhythm disturbances. Untreated OSA patients have noticeably higher rates of nighttime arrhythmias including AFib, bradycardia, and pauses. These can become symptomatic over time and contribute to longer-term cardiac events.

Does treatment really reverse the risk?

Yes, when adherence is good. The clinical literature on CPAP shows that patients who use therapy at least 4 hours per night, on at least 70% of nights, reduce their cardiovascular event risk to a level comparable to OSA-free controls within 3 to 5 years. Blood pressure drops, AFib recurrence rates fall, daytime sleepiness resolves.

Adherence is the variable that matters. Patients who drop CPAP within months of starting don't see the benefit. Patients who stick with it do. Newer interventions, Zepbound for adults with obesity, hypoglossal nerve stimulation for select cases, oral appliance therapy, give patients more options when CPAP doesn't fit.

What should you do if you think you have OSA?

Start with a screening tool. The STOP-BANG questionnaire takes 90 seconds and tells you whether your risk is low, intermediate, or high. If you score 3 or higher, talk to your doctor about a sleep study. The American Academy of Sleep Medicine recommends home sleep testing as the first study for adults with moderate-to-high pretest probability of OSA, that is, most people who screen positive on STOP-BANG.

Advanced Sleep Medicine Services has performed home sleep testing throughout California since 1994. We are accredited by the Accreditation Commission for Health Care (ACHC), and our board-certified physicians review every study. Most major insurance plans cover the test. Call (877) 775-3377 if you have questions before scheduling.

Frequently asked questions

There is no single threshold, but cohort studies show measurable elevations in blood pressure within 1 to 2 years of untreated severe OSA, and meaningful increases in coronary disease and AFib risk by 5 to 10 years. The longer the disease goes untreated, the higher the risk.

The risk scales with severity. Mild OSA carries a smaller mortality elevation than severe OSA, and many patients with mild disease do well without immediate treatment if there are no other cardiovascular risk factors. Your physician will weigh severity, symptoms, and comorbidities.

Alternatives exist and they work. Oral appliance therapy from a qualified sleep dentist is appropriate for mild-to-moderate OSA. For adults with obesity-related OSA, Zepbound (tirzepatide) was FDA-approved in late 2024 specifically for moderate-to-severe OSA. Hypoglossal nerve stimulation (Inspire) is an implantable option for select severe cases. Your physician will help you choose.

Direct death during a single apnea event is rare and happens almost exclusively in patients with significant pre-existing heart disease. The far more common pathway is years of cumulative cardiovascular damage that ends in heart attack, stroke, or fatal arrhythmia — usually not during sleep.

Ready When You Are

Take a home sleep test in California

FDA-approved devices delivered to your door. Board-certified physicians review your results. 100+ insurance plans accepted.